Hostname: page-component-6bf8c574d5-956mj Total loading time: 0 Render date: 2025-02-16T20:33:11.339Z Has data issue: false hasContentIssue false
  • English
  • Français

Informing patients about tardive dyskinesia

Controlled trial of patient education

Published online by Cambridge University Press:  03 January 2018

Robert Chaplin  and
Andrew Kent
Robert Chaplin*
Affiliation:
Pathfinder Mental Health Service, London
Andrew Kent
Affiliation:
Division of Community Psychiatry, Department of Mental Health Services, St George's Hospital Medical School, London
*
Dr Robert Chaplin, Division of Community Psychiatry, Department of Mental Health Sciences, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

This paper evaluates the effects on knowledge and clinical stability of an educational intervention about tardive dyskinesia.

Method

Fifty-six patients receiving antipsychotic maintenance completed a questionnaire assessing their knowledge about tardive dyskinesia. After random allocation to either an educational intervention or a control group, their knowledge was reassessed at six months.

Results

Ninety-five per cent of patients completed the study. The study patients gained significantly more knowledge than the controls, who made modest gains. There were no significant differences in clinical outcome between the groups.

Conclusion

Patients can learn about serious toxic effects of antipsychotic treatment with a low risk of non-compliance. Discussion about tardive dyskinesia is necessary in the process of obtaining informed consent to treatment.

Type
Papers
Information
The British Journal of Psychiatry , Volume 172 , Issue 1 , January 1998 , pp. 78 - 81
Copyright
Copyright © 1998 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Benjamin, S. & Munetz, M. R. (1994) Community mental health centre practices related to tardive dyskinesia screening and informed consent to neuroleptic drugs. Hospital and Community Psychiatry, 45, 343–346.Google ScholarPubMed
Brown, C. S., Wright, R. G. & Christenten, D. B. (1987) Association between type of medication instruction and patients knowledge side effects and compliance. Hospital and Community Psychiatry, 38, 55–60.Google ScholarPubMed
Chaplin, R. & Potter, M. (1996) Tardive dyskinesia: screening and risk disclosure. Psychiatric Bulletin, 20, 714–716.CrossRefGoogle Scholar
Guy, W. (1976) ECDEU Assessment Manual for Psychopathology. Washington, DC: US Department of Health, Education and Welfare.Google Scholar
Kleinman, I., Schachter, D. & Koritar, E. (1989) Informed consent and tardive dyskinesia. American Journal of Psychiatry, 146, 902–904.Google ScholarPubMed
Kleinman, I., Schachter, D., Jeffries, J., et al (1993) Effectiveness of two methods of informing patients about tardive dyskinesia. Hospital and Community Psychiatry, 44, 1189–1191.Google Scholar
Macpherson, R., Jerrom, B. & Hughes, A. (1996) A controlled study of education about drug treatment in scihzophrenia. British Journal of Psychiatry, 168, 709–717.CrossRefGoogle Scholar
McGuffin, P., Farmer, A. & Harvey, I. (1991) A polydiagnostic system of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Archives of General Psychiatry, 48, 764–778.CrossRefGoogle ScholarPubMed
Munetz, M. R. & Roth, L. H. (1985) Informing patients about tardive dyskinesia. Archives of General Psychiatry, 42, 866–871.CrossRefGoogle ScholarPubMed
Nelson, H. E. & O'Connell, A. (1978) Dementia: the estimation of premorbid intelligence levels using the National Adult Reading Test. Cortex, 14, 223–244.CrossRefGoogle Scholar
Norusis, M. J. (1986) SPSS/PC+ Statistics. Chicago. IL: SPSS Inc.Google Scholar
Umbricht, D. & Kane, J. M. (1996) Medical complications of new antipsychotic drugs. Schizophrenia Bulletin, 22, 475–483.CrossRefGoogle ScholarPubMed
Woerner, M., Kane, J. M., Lieberman, J., et al (1991) The prevalence of tardive dyskinesia. Journal of Clinical Psychopharmacology, 11, 34–42.CrossRefGoogle ScholarPubMed
World Health Organization (1992) Tenth Revision of the International Classification of Diseases and Related Health Problems. Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.